This was confirmed in vivo in a thymoma tumor model, where the anti-tumor activity of adoptively transferred antigen-specific CD8+ T cells was significantly enhanced in Cat2-/-vs. wild-type mice as a result of decreased ability of Cat2-/- MDSCs to suppress T cell function and proliferation (136, 137). The gene discussed is SLC7A2; the disease is neoplasm.